Virulence genes and antibiotic susceptibilities of uropathogenic E. coli strains

Clinical Laboratory

Volumn 61, Issue 8, 2015, Pages 941-950

  Uzun, Cengiz ^a   Öncül, Oral ^b   Gümüş, Defoe ^c   Alan, Servet ^d   Dayioʇlu, Nurten ^c   Küçüker, Mine Anʇ ^c  

^a International Hospital Istanbul   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL YENI YUZYIL UNIVERSITY   (Turkey)

^d Department of Clinical Microbiology and Infections Diseases Memorial Health Group   (Turkey)

Author keywords

Acute uncomplicated urinary tract infection; Antibiotic resistance; Escherichia coli; Virulence factors

Indexed keywords

ADHESIN; AEROBACTIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BACTERIAL PROTEIN; CATECHOLATE SIDEROPHORE RECEPTOR; CEFIXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYTOTOXIC NECROTIZING FACTOR 1; FOSFOMYCIN; GENTAMICIN; HEMOLYSIN; OFLOXACIN; OUTER MEMBRANE PROTEIN T; PATHOGENICITY ISLAND MARKER; UNCLASSIFIED DRUG; UROPATHOGENIC SPECIFIC PROTEIN; ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ACUTE DISEASE; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; DISK DIFFUSION; FEMALE; FIMBRIA; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PYELONEPHRITIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; URINARY TRACT INFECTIONS; URINE; VIRULENCE;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS; URINE; VIRULENCE; VIRULENCE FACTORS;

EID: 84941695946     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2015.141131     Document Type: Article

References (41)

1. Li D, Liu B, Chen M, et al. A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections. J Microbiol Methods 2010;82:71-7.
2. Kulkarni R, Dhakal BK, Slechta ES, Kurtz Z, Mulvey MA, Thanassi DG. Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli. PLoS ONE 2009;4:1-9.
3. Hacker J, Blum-Oehler G, Janke B, Nagy G, Goebel W. Pathogenicity Islands of Extraintestinal Escherichia coli. In Kaper JB, Hacker J (eds) Pathogenicity Islands and Other Mobile Virulence Elements. Washington DC: ASM Press, 1999:59-76.
4. Sabaté M, Moreno E, Pérez T, Andreu A, Prats G. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 2006;12:880-6.
5. Johnson JR, Owens K, Gajewski A, Kuskowski MA. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 2005;43:6064-72.
6. Nougayrède JP, Fernandes PJ, Donnenberg MS. Adhesion of enteropathogenic Escherichia coli to host cells. Cell Microbiol 2003;5:359-72.
7. Ruiz J, Simon K, Horcajada JP, et al. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 2002;40:4445-9.
8. Struelens MJ, Denis O, Rodriguez-Villalobos H. Microbiology of nosocomial infections: progress and challenges. Microbes Infect 2004;6:1043-8.
9. Blum-Oehler G, Dobrint U, Janke B, Nagy G, Piechaczek K, Hacker J. Pathogenicity islands of uropathogenic E. coli and evolution of virulence. In Emödy L, Pal T, Hacker J, Blum-Oehler G (eds) Genes and proteins underlying microbial urinary tract virulence basic aspects and applications. New York: Kluwer Academic/Plenum Publishers, 2000:25-32.
10. Mandai P, Kapil A, Goswami K, Das B, Dwivedi SN. Uropathogenic Escherichia coli causing urinary tract infections. Indian J Med Res 2001;114:207-11.
11. Rozenberg-Arska M, Visser MR. Enterobacteriaceae. In Armstrong D, Cohen J (eds) Infectious disease. Barcelona: Mosby, 1999;8/17.1-8/17.11.
12. Baylis CL, Penn CW, Thielman NM, Guerrant RL, Jenkins C, Gillesipie SH. Escherichia coli and Shigella spp. In Gillespie SH, Hawkey PM (eds) Principles and Practice of Clinical Bacteriology. West Sussex, England: Wiley, 2006;347-67.
13. Bower JM, Eto DS, Mulvey MA. Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 2005;6:18-31.
14. Puente JL, Brettfinlay B. Pathogenic E. coli. In Groisman EA (ed) Principles of Bacterial Pathogenesis. California: Academic Press, 2001;388-428.
15. Roos V, Nielsen EM, Klemm P. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 2006;262:22-30.
16. Miyazaki J, Ba-Thein W, Kumao T, Obata Yasuoka M, Akaza H, Hayshi H. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. FEMS Immunol Med Microbiol 2002;25:23-6.
17. Wroblewska-Seniuk K, Selvarangan R, Hart A, et al. Dra/AfaE adhesin of uropathogenic Dr/Afa+ Escherichia coli mediates mortality in pregnant rats. Infect Immun 2005;73:7597-601.
18. Nowicki B, Selvarangan R, Nowicki S. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J Infect Dis 2001;183:24-7.
19. Braun V, Braun M, Killmann H. Iron Transport in E. coli: Crystal Structure of FhuA, an Outer Membrane Iron and Antibiotic Transporter. In Emödy L, Pal T, Hacker J (eds) Genes and Proteins Underlying Microbial Urinary Tract Virulence Basic Aspects and Applications. New York: Kluwer Academic/Plenum Publishers, 2000;33-44.
20. Yamamoto S. Molecular epidemiology of Escherichia coli. J Infect Chemother 2007;13:68-73.
21. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections. J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:4.
22. Anvari MA, Naderan M, Boroumand MA, Shoar S, Bakhshi R, Naderan M. Microbiologic Spectrum and Antibiotic Susceptibility Pattern among Patients with Urinary and Respiratory Tract Infection. Int J Microb 2014;2014:1-6.
23. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
24. Kahlmeter G; ECO. SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO. SENS Project. J Antimicrob Chemother 2003;51:69-76.
25. Stratchounski LS, Rafalski VV. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2. Int J Antimicrob Agents 2006;28:4-9.
26. Martinez JL, Baquero F. Interactions among strategies associated with bacterial infection: Pathogenicity, Epidemicity and Antibiotic resistance. Clin Microbiol Rev 2002;4:647-9.
27. Pezzlo M, York MK. Urine cultures. In Isenberg HD (ed) Clinical microbiology procedures handbook. 2nd ed. vol 1 Washington DC: American Society for Microbiology, 2004;3.12.1-3.12.31.
28. Takahashi A, Kanamaru S, Kurazono H, et al. Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J Clin Microbiol 2006;44: 4589-92.
29. Yamamoto S, Terai A, Yuri K, Kurazono H, Takeda Y, Yoshida O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS. Immunol Med Microbiol 1995;12:85-90.
30. Wayne PA. Performance Standards for Antimicrobial Susceptibility Testing Eighteenth Informational Supplement, CLSI document M100-S18. Clinical and Laboratory Standards Institute 2008.
31. Livermore DM, Brown DF. Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother 2001;48 (1):59-64.
32. Oliveira FA, Paludo KS, Arend LNVS, et al. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genetics and Molecular Research 2011; 10(4): 4114-25.
33. Arisoy M, Aysev D, Ekim M, et al. Detection of virulence factors of Escherichia coli from children by multiplex polymerase chain reaction. Int J Clin Pract 2006;60:170-3.
34. Usein CR, Damian M, Tatu-Chitoiu D, et al. Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Med 2001;5:303-10.
35. Arslan H, Azap O, Ergönül O, Timurkaynak F. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005;56:914-8.
36. McIsaac W, Mazzulli T, Moineddin R, Raboud J, Ross S. Uropathogen antibiotic resistance in adult women presenting to family physicians with acute uncomplicated cystitis. Can J Infect Dis Med Microbiol 2004;15:266-70.
37. Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ, EMERGEncy ID NET Study Group. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008;47: 1150-8.
38. Alabsi MS, Ghazal A, Sabry SA, Alasaly M. Association of some virulence genes with antibiotic resistance among uropathogenic Escherichia coli isolated from urinary tract infection patients in Alexandria, Egypt: A hospital-based study. J Global Antimicrobial Resistance 2014;2:83-6.
39. Smaoui H, Mahjoubi F, Boutiba I, et al. Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000): A multicenter study. Tunis Med 2003;81:390-4.
40. Karlowsky JA, Jones ME, Thornsberry C, Critchley I, Kelly LJ, Sahm DF Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents 2001; 18:121-7.
41. Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, Garcia-de-Lomas J, Spanish Surveillance Group for Urinary Pathogens. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 2007;20:68-76.